Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
99.22 USD | -1.47% | -0.42% | -0.65% |
10:56am | Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks | MT |
09:39am | Guggenheim Adjusts Price Target on Merck to $122 From $130, Maintains Buy Rating | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MERCK & CO., INC. | Other Pharmaceuticals | -1.85% | -0.42% | -0.65% | -16.34% | +8.64% | 255B |
Technical Rankings Surperformance
- Stock Market
- Equities
- MRK Stock
- Charts Merck & Co., Inc.
- Comparison Chart
MarketScreener is also available in this country: United States.
Switch edition